Sequences of a serotype 8 adeno-associated virus and vectors and host
cells containing these sequences are provided. Also described are methods
of using such host cells and vectors in production of rAAV particles.
rAAV8-mediated delivery of therapeutic and immunogenic genes, including
Factor VIII, is also provided.